All In MedTech

Device Trial Radar · NCT06561932

A Feasibility Study Implant of the WiSE® CRT System With an Intracardiac Pacemaker to Achieve Totally Leadless CRT

Last checked: Nov 19, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Dec 18, 2025

Primary completion

Apr 1, 2027

Study completion Apr 1, 2027

Sponsor

Lead sponsor
EBR Systems, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 20, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Assess the safety and efficacy of the co-implantation of the WiSE CRT System with an intracardiac pacemaker to provide totally leadless CRT.

Conditions

  • Heart Failure

Interventions

  • WiSE CRT SystemDevice

    The WiSE CRT System is an implantable cardiac system to provide left ventricular (LV) pacing stimulation in conjunction with a co-implanted system that provides right ventricular (RV) stimulation. In combination, the devices deliver biventricular (BiV) pacing.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Device and procedure related complications.Time frame: 1 month and 6 months
  2. Bi-Ventricular capture on 12 lead EKGTime frame: 1 month and 6 months

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Patients of Sunshine Coast University Hospital

    Birtinya, Queensland, Australia · Recruiting

  • Royal Brisbane and Women's Hospital

    Herston, Queensland, Australia · Recruiting

  • Patients of Gold Coast University Hospital

    Southport, Queensland, Australia · Recruiting

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.